McKesson Corporation reports developments tied to its role as a diversified healthcare services company and major pharmaceutical distributor. Company news commonly covers fiscal results and guidance, dividend declarations, capital allocation, share repurchase activity, and updates across core distribution, oncology and multispecialty, biopharma services, pharmacy technology, and medical-surgical product categories.
McKesson updates also include portfolio actions and governance changes. Recent company materials document the completed divestiture of its Norwegian retail and distribution businesses, marking its exit from European operations, alongside recurring communications about earnings events, healthcare conferences, and leadership succession matters.
McKesson Corporation (NYSE:MCK) is set to release its second-quarter fiscal 2021 financial results on November 3, 2020, before market open. A live webcast will be conducted at 8:00 AM Eastern Time for investors to review the results. The webcast, along with the earnings press release and financial materials, will be accessible on McKesson’s Investor Relations website.
McKesson is recognized for providing healthcare supply chain management solutions and was named one of the Most Admired Companies in the healthcare wholesaler category by FORTUNE.